SCHEMBL21217819

SCHEMBL21217819

CCC1CC(c2nnc(Nc3ccc4[nH]ncc4c3)[nH]2)=CC=C1OCCC(=O)NC(C)C

nearest known ligand 0.43

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ ROCK2 O75116 18/20 0.43
▸ ROCK1 Q13464 10/20 0.42
▸ CLK2 P49760 1/20 0.39
▸ BLK P51451 1/20 0.39
▸ CSNK2A1 P68400 1/20 0.39
▸ STK3 Q13188 1/20 0.39
▸ DYRK1A Q13627 1/20 0.39
▸ AURKB Q96GD4 1/20 0.39
▸ CLK4 Q9HAZ1 1/20 0.39
▸ STK17A Q9UEE5 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24094395 0.93 ROCK2 (0.48) ROCK2ROCK1CLK2BLKCSNK2A1
SCHEMBL21217914 0.89 ROCK2 (0.48) ROCK2ROCK1CLK2BLKCSNK2A1
SCHEMBL21217534 0.84 ROCK1 (0.45) ROCK2ROCK1CLK2BLKCSNK2A1
SCHEMBL24094355 0.84 ROCK1 (0.48) ROCK2ROCK1CLK2BLKCSNK2A1
SCHEMBL24610390 0.83 ROCK1 (0.46) ROCK2ROCK1CLK2BLKCSNK2A1
SCHEMBL22966736 0.80 ROCK1 (0.51) ROCK2ROCK1CLK2BLKCSNK2A1
SCHEMBL24610388 0.79 ROCK1 (0.50) ROCK2ROCK1CLK2BLKCSNK2A1
SCHEMBL24610234 0.79 ROCK1 (0.43) ROCK2ROCK1CLK2BLKCSNK2A1
SCHEMBL21217522 0.76 ROCK1 (0.49) ROCK2ROCK1CLK2BLKCSNK2A1
SCHEMBL21217618 0.76 MEN1 (0.39) ROCK2ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019145729-A9 HETEROCYCLYLAMINO-SUBSTITUTED TRIAZOLES AS MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE REDX PHARMA PLC (GB) 2020-07-30 — — WO disclosed
WO-2019145729-A1 HETEROCYCLYLAMINO-SUBSTITUTED TRIAZOLES AS MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE REDX PHARMA PLC (GB) 2019-08-01 — — WO disclosed
Send feedback